Biomerica

Yahoo Finance • 9 hours ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carc... Full story

Yahoo Finance • 6 days ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney Disease (CKD), wit... Full story

Yahoo Finance • 7 days ago

Biomerica Announces Reverse Stock Split

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse stock split of the issued and outst... Full story

Yahoo Finance • 8 days ago

Biomerica Reports Third Quarter Fiscal 2025 Financial Results

Total Revenue Increases 10% Year-Over-Year Delivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (th... Full story

Yahoo Finance • 2 months ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU Focus on Precision Medicine: Certificati... Full story

Yahoo Finance • 2 months ago

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced Reduced Abdominal Pain and Bloati... Full story

Yahoo Finance • last year

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th Annual Craig-Hallum Alpha Select Confer... Full story

Yahoo Finance • last year

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National Accounts hired along with first set of regiona... Full story

Yahoo Finance • 2 years ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate strategy is expected to enable it to... Full story

Yahoo Finance • 2 years ago

Biomerica Reports First Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash position, forecasted revenue growth and corporate strategy is expected to enable it to... Full story

Yahoo Finance • 2 years ago

Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test

IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ Detect colorectal disease at-home scre... Full story

Yahoo Finance • 2 years ago

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian Bioscience As CEO Kenny managed the sale of Mer... Full story

Yahoo Finance • 2 years ago

Biomerica Reports Fiscal 2023 Year End Results

Revenues excluding Covid test sales increased 15% for fiscal 2023 vs fiscal 2022 Successfully completed inFoods® IBS pilot program with one of the largest Gastrointestinal physician groups in the US inFoods IBS completes pre-launch phase... Full story

Yahoo Finance • 2 years ago

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical Data The Patent further describes Algorithms to help Determine Safety Levels of Food Ingredients, Offering a Personalized Appro... Full story

Yahoo Finance • 2 years ago

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Gastro Health is a leading gastroenterology group with over 380 GI physicians in the United States Clinical study results show patients who eliminated foods as determined by the inFoods® IBS test experience significant improvement in IBS S... Full story

Yahoo Finance • 2 years ago

Biomerica Reports Q3 Fiscal 2023 Results

For the nine months ended February 28, 2023 vs. the same period in 2022, revenues, excluding sales of Covid-related products, increased by 16%.InFoods® IBS Laboratory Developed Test (LDT) validation testing at the CLIA Lab has been complet... Full story

Yahoo Finance • 2 years ago

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the closing of its previously announced underwritten public offering of an a... Full story

Yahoo Finance • 2 years ago

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

IRVINE, Calif., March 03, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the pricing of its previously announced underwritten public offering. Biomer... Full story

Yahoo Finance • 2 years ago

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, announced today that it has commenced an underwritten public offering of its common stock. A... Full story

Yahoo Finance • 2 years ago

Barnwell Industries, Inc. Reaches Cooperation and Support Agreement With its Largest Stockholders

HONOLULU, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE-American: BRN) (“Barnwell” or the “Company”) announce today that it has entered into a cooperation and support agreement (the “Agreement”) with its two largest s... Full story